NEJM Interviews

NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

02.03.2021 - By NEJM GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Julie Gerberding is chief patient officer and executive vice president at Merck. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Gerberding and B.F. Haynes. Vaccine Innovations — Past and Future. N Engl J Med 2021;384:393-396.

More episodes from NEJM Interviews